ABVC BIOPHARMA, INC. (ABVC)


Stock Price Forecast

April 16, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ABVC BIOPHARMA, INC. chart...

About the Company

We do not have any company description for ABVC BIOPHARMA, INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

23

Exchange

Nasdaq

$0M

Total Revenue

23

Employees

$9M

Market Capitalization

-0.51

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ABVC News

ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404

19h ago, source:

ABVC BioPharma, Inc. (ABVC) announced the company, together with its affiliate Rgene Corporation entered into a licensing agreement ...

Biopharma Layoffs Roundup

21d ago, source: Contract Pharma

Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.

Theravance Biopharma (TBPH) Price Target Increased by 10.00% to 15.71

19h ago, source: Fintel on MSN

The average one-year price target for Theravance Biopharma (NasdaqGM:TBPH) has been revised to 15.71 / share. This is an ...

Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock

13d ago, source: Zacks.com on MSN

One stock that might be an intriguing choice for investors right now is Vor Biopharma Inc. VOR. This is because this security ...

NeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

11d ago, source:

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...